Immunoglobulin: A Potential Game-Changer in Corona Treatment
The Sindh Blood Transfusion Authority has given the green light to Dow University to collect plasma for the production of immunoglobulin (IVIG or intravenous injection), a move that has been welcomed by the medical community. This development comes after the National Bio-Ethics Committee approved the study earlier this month, paving the way for a potential breakthrough in Corona treatment.
What is Immunoglobulin?
Immunoglobulin, also known as intravenous immunoglobulin (IVIG), is a type of antibody that is derived from the blood of patients who have recovered from Corona virus infections. This treatment involves separating the antibodies from the plasma, which is the liquid part of the blood, and then purifying and concentrating them using ultrafiltration techniques. The resulting product, hyperimmunoglobulin, is a transparent and safe treatment that has shown promise in combating Corona.
How Does it Work?
The process of producing immunoglobulin is complex and involves several stages. First, blood samples are taken from patients who have recovered from Corona. The antibodies are then isolated and purified using chemical techniques, and finally, they are concentrated using ultrafiltration. This process removes any unwanted substances, including viruses and bacteria, resulting in a safe and effective treatment.
Effectiveness of Immunoglobulin
According to Professor Shaukat Ali, leader of the research team, immunoglobulin has shown significant promise in treating Corona. The treatment has been found to be effective against FDA-approved safe Lorsk and Corona, and has been used successfully in the global epidemic of storks, measles, and mumps. Additionally, transparent antibodies to tetanus, influenza, and rabies are also commercially available worldwide.
Advantages Over Plasma Treatment
Immunoglobulin treatment is distinct from plasma treatment, although it is derived from plasma. The key difference lies in the fact that immunoglobulin is a purified and concentrated form of antibodies, whereas plasma treatment involves the use of whole plasma. This makes immunoglobulin a more targeted and effective treatment, with fewer side effects.
FAQs
- Q: What is the difference between immunoglobulin and plasma treatment?
A: Immunoglobulin is a purified and concentrated form of antibodies, whereas plasma treatment involves the use of whole plasma.
- Q: Is immunoglobulin safe?
A: Yes, immunoglobulin is a safe and effective treatment that has been used successfully in various global epidemics.
- Q: How is immunoglobulin produced?
A: Immunoglobulin is produced by isolating and purifying antibodies from the blood of patients who have recovered from Corona, and then concentrating them using ultrafiltration techniques.
The research team at Dow University has made significant progress in producing immunoglobulin, with the first batch being produced in March 2020. The team has successfully isolated antibodies that have rendered Corona ineffective, and has stored them in experimental vials. However, large plasma donations are required to produce large-scale injections.
Professor Muhammad Saeed Qureshi, director of Dow University, has congratulated the research team on the permission to collect plasma and has instructed them to work hard to produce this immunoglobulin. The development of immunoglobulin as a treatment for Corona is a significant breakthrough, and it is hoped that it will play a crucial role in combating the pandemic.
